Latest filing published 17 Aug 2026 for MBX Biosciences, Inc., €221k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Hawryluk P. Kent in MBX Biosciences, Inc. The record holds 2 filings, for trades running from 4 August 2026 to 17 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 17 August 2026, the filings show a transaction worth €221k in MBX Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations